Ensuring clinically sound, cost-effective medication therapy is a critical function of pharmacists. Yet addressing the costly and potentially dangerous process of sterile IV compounding—one of the ...

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications. Compounded pharmaceutical dosage forms may be ...

Anesthesiologists often have to use intravenous and epidural medication packaged in large sizes, because this is the only way to purchase the medication from drug manufacturers. If given in full to a ...

In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later ...

Ottawa, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The global non-sterile compounding pharmacy market size was valued at USD 5.97 billion in 2024 and is predicted to hit around USD 12.11 billion by 2034, ...

The licenses were issued between January 24, 2024, and August 13, 2024, by the respective State Boards of Pharmacy following rigorous application and compliance processes that require MediVera to meet ...